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Abstract Important advances in the development of smart
biodegradable implants for axonal regeneration after spinal
cord injury have recently been reported. These advances are
evaluated in this review with special emphasis on the regen-
eration of the corticospinal tract. The corticospinal tract is
often considered the ultimate challenge in demonstrating
whether a repair strategy has been successful in the regen-
eration of the injured mammalian spinal cord. The extensive
know-how of factors and cells involved in the development
of the corticospinal tract, and the advances made in material
science and tissue engineering technology, have provided
the foundations for the optimization of the biomatrices
needed for repair. Based on the findings summarized in this
review, the future development of smart biodegradable
bridges for CST regrowth and regeneration in the injured
spinal cord is discussed.
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Introduction
Why is the corticospinal tract a proof of principle?
The corticospinal tract (CST) is considered the ultimate
challenge to demonstrate if a repair strategy is succesfull
in regeneration of the injured mammalian spinal cord. It all
started from the observations made after the use of periph-
eral nerve grafts into the lesioned spinal cord: a significant
regrowth of CNS axons was noted, although various popu-
lation of axons tracts including the CST did not respond
(David and Aguayo 1981; Richardson et al. 1980, 1984). In
line with this, the CST is often considered to be the most
difficult tract to regenerate, because the distance between
the injury of CST axons in the lesioned spinal cord and the
location of the cells of origin in the sensorimotor cortex
exceeds that of every other tract in the nervous system.
From these observations, it became and still is, a major
scientific challenge to develop a strategy to enhance and
stimulate regeneration of injured CST fibers in the lesioned
spinal cord. Whereas the CST is easy to anterogradely label
(the cells of origin are located in the cerebral cortex and thus
accessible), tract-tracing and identification of the CST fibers
is relatively simple. Furthermore, the fact that the CST
develops postnatally in the mammalian spinal cord resulted
in an extensive knowledge about factors and molecules
involved in the outgrowth of this tract and this might be
extremely helpful in the design of optimal repair strategies.
Repair of injured spinal cord and regeneration
of corticospinal tract
Repair of the injured mammalian central nervous system
(CNS) and, in particular, the spinal cord has already been
a major challenge for neuroscientists for many decades. The
complexity of the spinal cord with its many ascending and
descending fiber tracts, the numerous spinal cell popula-
tions, the inter-connectivity between various levels of the
spinal cord combined with the characteristic response after
an injury in the adult, as well as the variability in the
location and impact of the lesion in the clinical situation,
makes the development of appropriate repair strategies very
complex and difficult. Furthermore, in most cases of human
SCI, there is a significant loss of spinal cord tissue and
cavity formation is an important obstacle, impeding axonal
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cial within the development of repair strategies for regener-
ation of injured fibers is the bridging of the lesion, including
both the ingrowth of injured fibers into the graft (or bridge)
but certainly also further elongation and regrowth of axons
out of the graft into the host tissue. In this context, it is
important to understand that regeneration of injured nerve
fibers is a complex of sequences in time and place. In general,
regenerationorrepairofthe primary damageafter lesioningof
fibersimpliestheachievementofseveralsteps(Joosten1997):
(1) directed regrowth of injured axons within and around the
lesion-area; (2) elongation of the ascending and descending
axons into rostral and caudal spinal cord areas, respectively;
(3) specific target finding; (4) neo-synaptogenesis; and (5)
remyelination of the regrown axons. Regeneration finally
results in the re-establishment of functional synaptic contacts.
In contrast, regrowth is defined as the initial aspects of the
response of the injured fibers: i.e., sprouting and elongation.
In this review, the response of injured corticospinal (CST)
fibersisdiscussedinviewofthesproutingandelongationinto
implanted biodegradable structures, which act as a bridge for
these fibers in order to overcome the lesion area.
Biomatrices and bridging materials
From a clinical point of view, the limited access to autolo-
gous donor material and the immunological reactions in-
cluding allograft rejection have prompted the search for
artificial biomaterials that may be implanted as bridges into
the lesioned spinal cord. Bridging materials should ideally
have a structure that is easily modifiable, absorbable and
immunologically inert, whereas at the same time they can
serve as a scaffold for matrix molecules and cellular
implants (Novikova et al. 2003). Although not absolutely
necessary, another major quality of the ideal matrix is bio-
degradability, which needs to be timed and related to the
establishment of significant plasticity of the injured CNS
and in particular related to regrowth of the injured CST
fibers. Hence, among biosynthetic implants for tissue regen-
eration after SCI, both “Biodegradable natural polymers”
and “Biodegradable synthetic implants” are discussed with
special emphasis on the regrowth of injured (CST) fibers.
For understanding the selection and design of the biomatri-
ces or, often, so-called axon growth conduits, which are
needed for bridging the injury site, basically two aspects
are important: on the one hand, biomaterial technology and
on the other hand, detailed knowledge of the factors and
molecules needed for regrowth of the injured CST. Details
on molecules, factors and/or cells needed for regrowth are
often collected from studies on the development of an indi-
vidual CNS tract, as it has been shown that each CNS
tract needs axon tract-specific requirements for develop-
ment and regeneration (reviewed by Deumens et al. 2005
for the descending axon tracts in rat spinal cord). It is
intriguing to see and understand how outgrowing CST
fibers enter the spinal cord and are able to find their
appropriate target cell during development (see “Devel-
opment of the corticospinal tract”). The rat CST is often
used as a model in developmental studies (Stanfield
1992; Joosten and Bar 1999; Canty and Murphy 2008)
and this has led to an extensive knowledge about the
factors and molecules involved. Hence, intrinsic and extrinsic
factorsinvolvedinthedevelopmentoftheCSThaveprovided
the basis for many studies on CSTregrowth after spinalinjury
in the adult mammalian cord.
As mentioned before, another important aspect in the
development and optimalization of biomatrices for repair
and bridging of the lesion gap in the injured spinal cord
(and in particular the CST) is related to material science and
tissue engineering technology. Here, most know-how is
based on studies on repair after peripheral nervous system
(PNS) injury. Although autologuous peripheral nerve grafts
still result in a superior regenerative performance or “gold
standard” for peripheral nerve repair (Dellon and Mackinnon
1988), many investigations, including those using non-
resorbable and resorbable materials for bridging the lesion,
have been performed aiming at a further increase of the
therapeutic success-rate (reviewed by Deumens et al. 2010).
Also, the inclusion of biochemical signaling molecules or
cellular components into the conduits or biomatrices has led
to major advances in development of experimental repair
strategies for injured PNS (reviewed by Deumens et al.
2010). This has finally led to the approval of one non-
biodegradable nerve conduit and four biodegradable nerve
conduits for clinical use by the US Food and Drug Adminis-
tration (FDA) and from the European Union with a Confor-
mite Europeenne (or CE) certification. The advances made in
peripheral nerve repair strategies, in particular related to ma-
terial sciences including matrix design and surface modifica-
tion,aswellasthecreationofimplantabledevicesthatinclude
recognition domains for cell attachment, the use of internally
oriented matrices and the sustained release of neurotrophic
factors,has now led toanadvancedleveloftissueengineering
inthe PNSfield.This technologyand application ofadvanced
materials in the PNS field is far ahead of that in use and repair
of injured CNS but at the same time may inspire tissue
engineers to further develop even more “intelligent scaffolds”
that are needed in the very complex situation of the injured
spinal cord.
The present review will start with an update on our
current knowledge on the factors involved in outgrowth of
the developing CST. Then, the focus will shift to regenera-
tion of injured CST after spinal cord injury in view of the
strategies used to enhance this regrowth. The effect of local
application of biodegradable bridging structures and bioma-
trices with or without supporting cells/molecules, in view of
376 Cell Tissue Res (2012) 349:375–395the impact on CST re-growth, is discussed. Finally, the
findings are discussed with emphasis on future design of
smart implants and regeneration of CST in human SCI.
As should be stressed, the impact of the secondary dam-
age and the inflammatory response that accompanies neural
injury and, related to that, the immunomodulatory strategies
in order to enhance CST re-growth is not the main focus of
this review. The effects of inflammation on axon regenera-
tion in the mammalian spinal cord are highly complex (for
review, see Benowitz and Popovich 2011): mainly destruc-
tive in the lesion center and often pro-regenerative in the
area of secondary damage, which is located at a distance of
the primary lesion. Although not included into this review, it
should be noted that the inflammatory response as related to
secondary damage after SCI may be closely interacting and
direct the capacity and impact of bridging structures for
repair. Inflammation has, for instance, been reported to
interact and augment the ability of neurotrophins like
Neurotrophin-3 (NT-3) to promote axon growth of CST
fibers after spinal cord injury (Chen et al. 2008).
Development of the corticospinal tract
The outgrowing CST
The outgrowth of the corticospinal tract (CST) into the
spinal cord of the rat is characterized by two phases, which
both occur postnatally: a white matter tract formation on the
one hand and the spinal gray matter target innervations on
the other. Both phases are closely related and have been
shown in various anterograde tract-tracing studies (Schreyer
and Jones 1982; Joosten et al. 1987;C u r f se ta l .1995;
Joosten and Bar 1999). The outgrowth of main bulk of
CST fibers is preceded by a relatively small number of pio-
neering axons with large growth cones (Gorgels et al. 1989).
The majority of the CST axons follow these pioneering
growth cones in tightly fasciculated bundles located in the
ventralmost part of the dorsal funiculus (vDF) of the rat spinal
cord. This staggered mode of outgrowth into the spinal white
matter is shown in Fig. 1. After a waiting period (Donatelle
1977; Gribnau et al. 1986), the axons exit from the vDF by
collateral branching in a rostro-caudal wave along the spinal
cord(KuangandKalil1991).Initially,thesecollateralsbranch
extensively in the gray matter, especially in the cervical and
lumbar enlargements (Karimi-Abdolrezaee et al. 2002) where
they finally transmit signals to muscles that control fore- and
hindlimbs, respectively. This process of extensive collateral
branching and arborization in the spinal gray is finally refined
based on the connections made and mediated by the activity-
dependent remodeling of the synaptic connections between
the CST fibers and target interneurons (Ohno and Sakurai
2005).The interneuronshavealready then madecontactswith
the motoneurons in the ventral gray matter and the latter
already have functional connections with the flexor and ex-
tensormusclesin fore-andhindlimbs.Inviewoffunctionality
and the acquisition of voluntary movements, as this is the
main function of the CST, it should be noted that learning
the full complexity of locomotion is only possible if the CST
is innervating not only the cervical but also the lumbar spinal
cord. Then, finally, when the CSTis fully grown, at the end of
the third postnatal week, although myelination of fibers in the
vDF may still take place (Gorgels 1990; Leenen et al.1989),
the animals are able to execute very precise movements of the
different muscle groups in particular in the forelimbs. This is
therefore why the grasping test, which depends on the fine
movements and interaction between forelimb digits, is con-
sidered a behavioral outcome of functionality of the CST in
rats (Stackhouse et al. 2008).
Whereas the outgrowth of the dorsal and main component
of the CST is described in detail and based on various tract-
tracing and electron-microscopic studies, the development of
the relatively small ipsi-lateral uncrossed CST component
located in the ventral funiculus has received much less atten-
tion. The ventral CST penetrates the spinal cord white matter
up to lumbar levels (Joosten et al. 1992) and finally forms
branches into the spinal gray (Brosamle and Schwab 1997;
Gianino et al. 1999). In view of the regeneration and regrowth
of the CSTafter spinal cord injury, the presence of this ventral
Fig. 1 Schematic representation of outgrowth and guidance factors
involved in the developing corticospinal tract in rat spinal cord. Vimen-
tin immunoreactive astroglial cells (a) are situated in longitudinal tiers
with their processes perpendicular to the outgrowing CST pioneer
fibers and their growth cones (gc) (Joosten and Gribnau 1989a, b).
The embryonic form of N-CAM is present on the growth cones of the
pioneer CST fibers. The later-arriving CST fibers are guided by the cell
adhesion molecule L1. During spinal gray matter target innervation,
mainly through the formation of so-called back-branches, a tropic factor,
probably NT-3, is released by either the CST target (inter)-neurons (in)o r
astroglial cells (a). Adapted from (Joosten 1997), with permission
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comment that lesion models focused at the dorsal part of the
spinal cord in which in particular (and only) the vDF is trans-
ected orcompressed, the factthatthe ipsilateral ventral CSTis
still intact may lead to incorrect conclusions on the regrowth
or regenerative response of lesioned CST fibers.
Factors involved in CST outgrowth during development
The developing CNS is characterized by an overproduction
of neurons, dendrites and axons in order to ensure that each
target cell structure eventually receives an adequate input.
This overproduction is followed by a process of elimination
that is needed to match the size of the innervating popula-
tion of cells and the capacity of the target: “system match-
ing”. In the context of this phenomenon, a phase of naturally
occurring cell death was observed in many parts of the CNS
(Hamburger and Oppenheim 1982). However, cell death is
virtually absent in the layer Vof the cortex, where the large
pyramidal cells are located, which are the cells of origin of
the CST (Armand 1982, among others). Not cell death but
the overproduction and subsequent elimination of long CST
projections plays an important role in CST development as
elegantly shown in a double-labeling retrograde experiment
(Stanfield 1982). In the context of regeneration of the CST
after spinal injury, it has long been a controversy whether
the cells of origin of the CST die or not. It has even been
claimed that neurotrophic factors like neurotrophin-3 or
brain-derived neurotrophic factor (BDNF) are needed for
survival of adult axotomized CST neurons and applied to
the cortex, because when a cell body dies, the axon dies as
well (Carlson et al. 2000). Hence, in order to induce or
establish repair after spinal cord injury, both an intervention
aimed at the survival of the cells of origin and at the same
time those aimed at enhancing the axon regeneration at the
lesion site are needed. However, a recent detailed imaging
and histological analysis on Wallerian degeneration and
axon number in the medullary pyramids of adult rats after
acute SCI showed that SCI caused no cell death of CST cell
bodies in the cortex (Nielson et al. 2010). The latter impli-
cates that therapeutic strategies aimed at promoting CST
axon regeneration in the spinal cord do not require a sepa-
rate intervention aimed at protection of cellular death of the
cells or origin (Nielson et al. 2010).
The developing mammalian CST is characterized by a
staggered mode of outgrowth (Schreyer and Jones 1982;
Gribnau et al. 1986). A main wave of later-arriving axons
is preceded by a number of pathfinding axons, which are
characterized by dilatations at their distal ends: the growth
cone (Joosten et al 1992; for review, see Joosten and Bar
1999). These pioneer growth cones are 10 µm wide and 25
µm long and include fusiform, clavate, lamellipodial and
filopodial morphologies, whereas the later-arriving axons
are relatively straight and about 0.5 µm in diameter (Gorgels
1991; Joosten et al. 1992; Joosten and Bar 1999). The
pioneer fibers must receive information from the environ-
ment, which directs their direction and speed of growth,
whereas those axons that follow are guided by means of
fasciculation with the pioneers (for review, see Joosten
1997) (Fig. 1).
The environment of the DF that the pioneer CSTwill face
upon arrival is predominantly made up of interweaving
processes of immature glial cells, with some neuronal pro-
cesses from the surrounding gray matter (Schreyer and
Jones 1982). From a molecular point of view, there is
evidence that Eph-ephrin signaling is involved in the gen-
eration of the DF, as, for instance, Ephrin A4 and its ligand
ephrin-B3 are expressed throughout the embryonic DF
(Greferath et al. 2002; Dottori et al. 1998; Kullander et al.
2001). Detailed immunohistological studies have shown
that in particular astroglial cells are pivotal in guiding the
pioneer CST growth cones: vimentin-immunoreactive im-
mature astroglial cells are situated in longitudinal tiers with
their processes perpendicular to the outgrowing CST growth
cones (Joosten and Gribnau 1989a) and, moreover, junc-
tional specializations between these growth cones and the
glial processes have been documented (Fig. 1) (Joosten and
Gribnau 1989a; Gorgels 1991). In addition to the glial cell-
mediated mechanical way of routing, molecular cues have
been identified to be important in this guidance and glial
cell-mediated interaction: the presence of the embryonic
form [highly poly-sialylated (PSA)] of the cell adhesion
molecule [neural cell adhesion molecule (N-CAM)] on the
CST growth cones in spinal white matter strongly suggests
involvement of this molecule in the guidance of the CST
fibers (Joosten 1994; Joosten et al. 1996; Daston et al.
1996). The bulk of later-arriving fasciculating axons is
guided through the differential adhesiveness by the cell
adhesion molecule L1 (Fig. 1) (Joosten and Gribnau
1989b; Joosten et al. 1990). The insulin growth factor-1
(IGF-1) has also been implicated in axonal elongation
through the vDF (Ozdinler and Macklis 2006) as shown
through the in vivo blockade of the IGF-1 receptor using
antibodies; this significantly reduced the CST axon out-
growth in the spinal white matter (Ozdinler and Macklis
2006). Another interesting finding is the role of Wnt pro-
teins in CST growth cone guidance: both Wnt1 and Wnt5a
were shown to repel CST axons due to a repulsive signaling
mediated through the Ryk receptor (Liu et al. 2005); in fact,
CST axons are repelled from areas of high Wnt expression
and as a result prevent the CST axons from exiting the DF.
After a waiting period of several days, some CST fibers
change their direction, veering away from the tract and
directly entering the adjacent spinal gray matter (Joosten et
al. 1994; Joosten and Bar 1999). Nevertheless, CST target
innervation mainly occurs by formation of collateral
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1994), which occurs at defined locations or so-called ”deci-
sion-points” (O’Leary and Terashima 1988; Kuang et al.
1994; Joosten et al. 1994). Most of the collateral branching
occurs at cervical and lumbar regions (enlargements), which
are the two major CST termination zones in the spinal cord.
The spinal target innervation of the CST fibers are thought
to be mediated through gradients of diffusible neurotropic
molecules, which are either released by neuronal or by glial
target cells located in the target areas, as shown in vitro
collagen co-culture studies (Fig. 1) (Heffner et al. 1990;
Joosten et al. 1991, 1993, 1994; Sato et al. 1994). A major
candidate neurotrophin is the NT-3 as its receptor tyrosine
kinase -3 (trk-3) is present on the cells of origin of the CST
(Frisen et al. 1993). Levels of NT-3 mRNA in spinal motor
neurons (i.e., CST target cells) are significantly increased at
early postnatal time points as compared to the adult spinal
cord where NT-3 mRNA cannot be detected (Ernfors and
Persson 1991). In addition to the neurotrop(h)ic chemotactic
guidance of outgrowing CST fibers, contact-mediated guid-
ance is also thought to be involved in the CST target
innervations: the CST fibers discriminate target tissues by
direct contact with the gray matter, as shown in in vitro co-
culture experiments (Kuang and Kalil 1991).
Furthermore, extracellular matrix (ECM) molecules and
myelin-associated proteins may act as outgrowth inhibitory
molecules and be implicated in the outgrowth and restriction
of CST pioneer fibers to leave the DF during their descent
(SchwabandSchnell1991).Highlevelsofchondroitinsulfate
proteoglycan is observed in the area surrounding the DF,
particularly at the time of arrival of the leading pioneer CST
fibers (Hsu et al. 2005), suggesting the formation of a barrier
to the exit of the CST fibers in the DF white matter.
In summary The various diffusible as well as contact-
mediated guidance cues, which might either be permissive
orrepellentforoutgrowthofCSTfibersinspinalwhitematter,
havebeen described and are identified. The three-dimensional
structure and arrangement of immature outgrowth promoting
cells or glial cells including outgrowth permissive cell adhe-
sion molecules (N-CAM/ L1), in the environment of the vDF
upon and during the arrival of the first CST pioneer fibers, is
important for guidance. For correct target innervation (back-
branching of fibers) and contact formation of the CST fibers,
both outgrowth stimulating as well as outgrowth inhibitory
molecules including various CAMs, EphA4, growth associat-
ed protein 43 (GAP-43), chondroitin sulphate proteoglycans
and identified (NT-3) (or as yet unidentified) neurotrophins
are needed. The know-how on cells and molecules involved
in CST outgrowth during development is important in the
design and creation of optimal bridging structures, which are
used to enhance and direct the regrowth of injured CST fibers
in adult mammalian spinal cord.
Biomatrices and bridging structures for CST regrowth
after SCI
A damaged peripheral nerve is able to regrow its axons
through the distal stump, mainly via the bands of Bungner
thatarecomposedoftubesofbasallaminaenclosingSchwann
cells (SC). A prerequisite for this regrowth of injured PNS
axons is the presence of a physical continuity. Hence, in large
peripheral lesion gaps, many bridging materials have been
tested to allow and stimulate the regrowth of injured fibers.
In contrast to the injured PNS axons, those of the CNS fail to
regenerate,althoughlocalsproutingcanoccur.Thepioneering
work of Ramon Y Cajal (1928) indicated that, if the environ-
mentissuitable,axonsfrominjuredcentralneuronsareableto
regrow. With the development of advanced anatomical tract
tracing techniques, the regrowth of CNS axons into the pe-
ripheral nerve grafts was convincingly demonstrated (David
and Aguayo 1981). Although this peripheral graft allows
axons of various CNS populations to regrow, the PN-graft
seems to be rather selective for certain categories of CNS
axons. In this respect, it is important to know that injured
CST axons do not respond to PN-grafting of the lesioned
spinal cord (Richardson et al. 1980, 1984). These findings
clearly initiated a large body of research on use and develop-
mentofbiodegradablebridgingmaterials(naturalpolymersor
syntheticinorigin)with orwithoutsupportingcells/molecules
in order to stimulate the regrowth of injured CSTaxons.
Biodegradable natural polymers
Avarietyofbiodegradablenaturalpolymershavebeenusedas
implants and cell carriers for repair after SCI. Among them
collagen type I and alginate have received most attention.
Collagen
Developmentalstudieshaveshownthatenvironmentalfactors
such as extracellular matrix molecules (ECM) components
[e.g., laminin, fibronectin, heparin sulphate, collagen and/or
cell adhesion moelcuels (CAMs)] are transiently expressed
during periods of axonal elongation (Botz et al. 1990), includ-
ing the CST (for review, see Canty and Murphy 2008). As a
biodegradable material, the ECM component collagen is
promising due to its abundant sources, good plasticity and
biocompatibility (Lee et al. 2001). Axonal regrowth is
reported after collagen is grafted parallel to the axis of the
transected spinal cord (Yoshii et al. 2004). Besides a direct
growth-promotingeffect(Harrisetal. 1985),collagenimplan-
tationintothelesiongapoftheinjuredspinalcordmayalsobe
important in stimulating the regrowth of lesioned CST fibers
by functioning as a scaffolding structure. Collagen (type 1) is
composedofacross-linkedlatticenetworkoffibersandfibrils
with abundant inter-fibrillary spaces (Gross and Kirk 1958)
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gen hydrogels for neural tissue (Harris et al. 1985). Implanta-
tion of a collagen gel into the lesioned adult rat spinal cord
may result in ingrowth of injured fibers (Marchand and
Woerly 1990) including CST fibers (Joosten et al. 1995a).
The latter is, however, considerably affected by the method of
application (Joostenetal. 1995a):whereas the application ofa
fluid collagengraft,which self-assemblesinsitu, results inthe
invasionofastroglialcells and atthe sametime(4weeks post-
implantation) ingrowth of a significant number of anterog-
radely labeled CST fibers, the implantation of an already self-
assembled gel resulted in the absence of any ingrowing CST
fibers (Joosten et al. 1995a). It is suggested that the optimal
integration of the fluid collagen matrix and re-establishment
of a physical continuity to the transected spinal cord may
accountfortheingrowthofCSTfibers(MarchandandWoerly
1990; Joosten et al. 1995a). However, no regrowth of injured
CST fibers caudal to the graft was noted in either of the
collagen implants, which either suggest that the caudal stump
of the adult spinal cord is still non-permissive or that the
regrowth of the CST fibers in the fluid collagen graft, despite
the presence of invading astroglial cells, lacks the presence of
directed guidance. Despite the fact that CSTaxons grow into
the collagen matrix placed between the stumps of the partially
transected spinal cord, the matrix became denatured after
2–3 months and, as stated by Marchand and collegues, the
invasion of injured axons into the matrix is then not fully
developed (Marchand et al. 1993). The collagen biomatrix
becomes highly disorganized by the massive infiltration of
endogenously synthesized connective tissue. In this, the arti-
ficial matrix is not able to withstand the tendency of the
newly produced (connective) collagen to form aggregates,
thus leading to its denaturation. The stability of the biomatrix
could be improved by co-prepitation of the collagen with
chondroitin-6-sulfate or chemically cross-linked with carbo-
diimide (CD) (Marchand et al. 1993) .T h eC Dc o l l a g e nc r o s s -
linking treatment improved the stability of the collagen type I.
The stabilized collagen type 1 biomatrix modified the normal
host scarring process, which then favored axonal regeneration
(Marchand et al. 1993). Unfortunately, analysis of CST re-
growth was not included in this study.
The solid collagen implant may have certain advantages
over the fluid injection of collagen with respect to manipulat-
ibility/controllability, which is particularly important if the
collagen acts as a vehicle for the local application of cells
and/or neurotrophic factors (Joosten et al. 1995a). Immature
astroglial cells embedded in a collagen gel were implanted
into the lesioned spinal cord of the rat, thereby mimicking to
some extent the developmental situation (compare and see
“Developmentofthecorticospinaltract”;Joos te nandGr ib nau
1989a). In this context, it is important to note that astroglial
cells derived for neonatal rat cortex was used. Although it has
been documented that target-derived astroglial cells
preferentially stimulate axon length of defined neuron popu-
lations (Rousselet et al. 1990, among others), in vitro experi-
ments have shown that CSTaxon growth is not influenced by
the anatomical origin (cortex vs. spinal cord) of the astrocytes
(Dijkstra et al. 1999). Although the use of collagen as a
vehicle to transplant neonatal cortical astroglial cells into the
lesioned spinal cord of the adult rat resulted in a significant
increase in the number of ingrowing neurofilament positive
fibers, including anterogradely labeled CST axons, no
improvements were noted in locomotor behavior (Joosten et
al. 2004). The close contact between the transplanted imma-
ture cortical astroglial cells and the regrowing CST fibers in
the collagen matrix suggest a contact-mediated guidance
phenomenon, although it might also be possible that the
enhanced ingrowth is due to the release of neurotrophins like
Neurotrophin-3 (NT-3), a factor known to be released by
neonatal astrocytes (Althaus and Richter-Landsberg 2000).
On the other hand, no re-entry of regrowing CST axons was
observed into the host tissue after the implantation of imma-
ture cortical astroglial-collagen grafts (Joosten et al. 2004).
This indicated that, in addition to the collagen-astroglial ma-
trices, additonal stimulation will be necessary. In this respect,
the olfactory ensheating cells (OECs) were very promising
candidates. OECs are a unique population of peripheral glial
cellssharing bothSchwann cell and atthe sametime astrocyte
characteristics (Barnett and Chang 2004; Lakatos et al. 2000).
Moreover, the transplantation of OEC’si n t ov e r yr e s t r i c t e d
spinal cord lesions resulted in an extensive elongation of
injured CST fibers into the caudal host tissue and this is
associated with functional restoration of specific motor tasks
(Li et al. 1997; Ramon-Cueto et al. 1998, 2000). After injec-
tion of the OECs into very small lesions in the spinal cord,
these cells have been reported to migrate into the CNS, there-
by promoting the re-entry of regenerating axons (Ramon-
Cueto and Nieto-Sampedro 1992). Although the injection of
OECs showed promising effects on the repair of injured
CST axons across small and chronic lesion gaps (Li et al.
1997, 1998; Ramon-Cueto et al.1998, 2000; Keyvan-Fouladi
et al. 2003), the effects of injecting OECs directly into a
large lesion gap of the injured spinal cord were very
limited (Li et al. 2004) . In order to improve this out-
come, the use of collagen as a vehicle has been consid-
ered and the behavior and characteristics of OEC on 2-D
as well as 3D collagen matrices have been studied (Wang
et al. 2006). These in vitro studies suggested that 3-D
collagen scaffolds provide suitable environments for the
OECs to maintain their morphology as well as several
important functional phenotypes (including the produc-
tion of neurotrophic factors) and all these could be helpful
for the effective treatment of SCI. However, no in vivo follow
up studies have been reported that show the possible benefi-
cial effect of these 3D collagen OEC scaffolds and regenera-
tion of CST fibers after SCI.
380 Cell Tissue Res (2012) 349:375–395It is interesting to note that the response of CSTaxons on
the OEC implanted cells, at least in the smaller spinal
lesions, is probably mediated by the release of the diffusible
neurotrophic molecule NT-3 (Ramon-Cueto et al. 1998), a
molecule known to be important during development and
guidance of the outgrowing CST (see “Development of the
corticospinal tract”).
As the release of neurotrophins by OECs transplanted
into the lesioned spinal cord may be important in the stim-
ulation of the regrowth of injured axons, including the CST
fibers, one could hypothesize that the local delivery of
neurotrophic molecules by itself is sufficient for CST re-
growth. Here, collagen may also act as a vehicle for local
application and thus various experiments have been
designed where either known neurotrophic factors like
BDNF or NT-3, or extracts derived from postnatal spinal
target tissue known to release tropic substances that attract
the CST fibers, (see “Development of the corticospinal tract”)
were used.
In view of the idea that regeneration is based on a
repetition of the development, the use of target-derived
extracts is challenging. Based on the in vitro findings that
chemotropic factors are released by the spinal gray target
and specifically direct and attract outgrowing CST fibers
(Heffner et al. 1990; Joosten et al. 1991, 1994; Sato et al.
1994; see “Development of the corticospinal tract”), it was
hypothesized that timed postnatal cervical or lumbar spinal
cord gray matter extracts may contain the appropriate trop
(h)ic factor to stimulate CST re-growth into the collagen
matrix, after SCI. Indeed, transplantation of the extracts
using collagen type I as a vehicle into the T8/T10 dorsally
hemisected spinal cord of an adult rat resulted in a very
strong increase in the re-growth of injured CST fibers,
although no regenerating CST fibers were noted in the
caudal host tissue (Joosten et al. 1995b). Several lines of
evidence suggested that NT-3 (or BDNF) might be the
neurotrophic factor involved. And, indeed, similar results
were reported after the local application of NT-3 into the
lesioned spinal cord of an adult rat using collagen as a
vehicle: collagen containing NT-3 implantation resulted in
a directed regrowth of the injured CST fibers towards the
source of the NT-3 (Houweling et al. 1998). Also, trans-
plants of modified NT-3 secreting fibroblasts embedded in
collagen type I increased the regrowth of severed CST
axons; however, surprisingly not into the graft (Grill et al.
1997). The avoidance of the regrowing CST axons into the
collagen graft area containing the NT-3 secreting fibroblasts
was compensated by the presence of regrowing CST fibers
underneath the T7 dorsal hemisection lesion sites (Grill et al.
1997). Interestingly, the rats with NT-3 containing collagen
implants as well as those containing the NT-3 secreting
fibroblasts showed a similar improvement at the functional
level as measured with the gridwalk test (Grill et al. 1997;
Houweling et al. 1998). As the absence of CST regeneration
caudal to the lesion results in improvements in the gridwalk
test, it was concluded that this behavioral test is not sensitive
enough for detection of CST-mediated functional regenera-
tion (Houweling et al. 1998). For correct analysis of CST
regeneration after mid-thoracic SCI a more sensitive func-
tional test is needed.
CST regrowth has been studied based on local applica-
tion of various other neurotrophic factors. BDNF and NGF
both secreted by genetically modified fibroblasts were ap-
plied to the lesioned spinal cord using collagen type I as a
vehicle and bridging substance (Blesch et al. 1999; Tuszynski
etal.1997).Inparticular,BDNFisaninterestingcandidatefor
stimulation of regrowth of injured CST fibers due to the fact
that the functional receptor of BDNF, full length tyrosine
kinase B (trkB), is present on the somata of CS neurons
in the sensorimotor cortex (Lu et al. 2001). However,
without exception, the local deliveries of neurotrophic
factors using a collagen-gel as a vehicle and applied into
the injured spinal cord did not result in regrowth of the
CST fibers into areas caudal to the lesion (Blesch et al.
1999; Tuszynski et al. 1997; Joosten et al. 1995b;H o u w e l i n g
et al. 1998; Tobias et al. 2005).
In summary The strategies described are based on local
delivery of neurotrophins (either pure or produced by ge-
netically modified fibroblasts) using collagen as a vehicle
that is not sufficient for CST regrowth and re-establishment
of functional connections. Although collagen can serve as a
bridge to connect the rostral and caudal portions of the
injured spinal cord (Joosten et al. 1995a), significant
improvements need to be made before optimal regeneration
of CST fibers can be established. In this respect, recent
developments need to mentioned: the establishment of an
increased binding ability of either NT-3 (Fan et al. 2010)o r
BDNF (Liang et al. 2010; Han et al. 2010) to collagen,
based on the construction of recombinant fusion proteins;
the development of recombinant collagen-binding NT3
(CBD-NT3), consisting in a collagen-binding domain (CBD)
and native NT3; as well as the same time the formation of
linear ordered collagen scaffolds that direct the outgrowing
CST fibers, are all important improvements (Fan et al. 2010).
Indeed, the use of linear ordered tail collagen scaffolds
(LRTC) loaded with CBD-NT-3 was shown to promote ante-
rogradely labeled CST regrowth into the matrix after trans-
plantationintoacompletespinaltransection(Fig.2)(Fanetal .
2010). However, here again, no regeneration of CST fibers
was noted into the caudal host tissue (Fan et al. 2010), al-
though the authors reportat the sametime functionalrecovery
as assessed by use of the Basso-Beattie-Bresnahan (BBB)
locomotor rating scale (Basso et al. 1995) or the gridwalk.
As discussed before, neither the BBB nor the gridwalk tests
are correlated to the functionality of the CST.
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Alginate is a naturally derived polysaccharide extracted
from brown seaweed and composed of 1,4-linked B-D-
mannuronate and 1,4-linked alpha-L-glucuronate. It forms
a gel by cross-linkage with calcium ions, is immunological-
ly inert- and not digested by mammalian cells. As the
calcium ions gradually diffuse out of the gel, it slowly
degrades and is excreted in the urine (Novikova et al.
2003). Although the commercially available alginate is
thought to be cytotoxic, the development of a novel alginate
sponge, cross-linked with covalent bonds, no longer showed
inhibitory effects on cell proliferation in vitro. The use and
implantation of freeze-dried alginate sponges into the lesion
gap in completely transected spinal cord of young adult rats
has been shown to stimulate the re-growth of myelinated and
Fig. 2 Detection and quantification of biotinylated dextran amine
(BDA)-labeled corticospinal tract (CST) fibers. (a–j)P h o t o m i c r o -
graphs of the lumbar region of the spinal cord showing axons regen-
erating in the CST labeled with BDA in cross-sections. The sections
were 400 μm from the border of the lesion and the caudal stump. There
were differences in the appearance of the lesion and the caudal portion.
Arrows indicate BDA-labeled CST fibers (scale bars 50 μm). The
numbers of BDA-labeled fibers in the lesion (k) and the caudal stump
(l) and the percentages of positive BDA-labeled fibers per section in
the lesioned and caudal segments (m) are shown. There was a statis-
tically significantly larger positive area in the LRTC/C3 group than in
the other groups (*p<0.05, **p<0.01 as determined by the two-tailed
Student's t test). LRTC/PBS linear rat-tail collagen/phosphate-buffered
saline animals, LRTC/N3 linear rat-tail collagen/neurotrophin-3 ani-
mals, LRTC/C3 linear rat-tail collagen/collagen-binding neurotrophin-
3 animals, C3-only collagen-binding neurotrophin-3 only animals, t-
only transected-only animals). Adapted from Fan et al. (2010), with
permission
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Kataoka et al. 2004). Regrowth of both ascending and
descending axons that traversed the alginate-filled gap includ-
ed the re-entrance of the host spinal cord and the formation of
electrophysiological active neuronal connections with host
neurons (Suzuki et al 2002). Regenerating axons grew
1–1.5 cm rostrally and 200–300 mm caudally from the lesion
through the host spinal cord tissue. Twenty-one weeks after
implantation, many regenerated axons from the CST were
observed throughout the gap in six animals. Some HRP-
labelled CST axons extended a further 200–300 mm through
thewhiteandgraymattercaudaltothegapinfouranimalsand
the number of regenerated CSTaxons was much smaller than
that of regenerated axons in the ascending pathway (Suzuki et
al. 2002). The fact that re-growing CSTaxons were able to re-
enter the host tissue after use of the alginate hydrogel sponge,
as compared to the absence of re-entry of CST fibers after
collagen implants (see “Collagen”) was suggested to be relat-
ed to the fact that collagen is a component of the extracellular
matrix that enhances proliferation of fibroblasts. The accumu-
lation of fibroblasts in the spinal cord gap may act as an
additional physical barrier. From this, it should be concluded
that the alginate sponge has major advantages over the
collagen-gel implants. However, the report that alginate
freeze-dried sponges stimulate regrowth of CST fibers, in-
cluding the re-entry into the host tissue, is at present limited
to one publication (Suzuki et al. 2002).
The development of alginate hydrogels as potential cell
carriers for neurotransplantation has been considered (Novikova
et al. 2006;T o b i a se ta l .2001, 2005). Alginate hydrogels may
act as carriers for extracellular matrix molecules and cell lines,
stem cells and neurotrophic factors. In vitro studies have shown
that alginate hydrogels transformed olfactory nerve ensheating
cells (ONEC), Schwann cells (SC) and bone marrow-derived
stem cells (BMSC) into atypical cells with spherical shape and
decreased the metabolic activity of the cells (Novikova et al.
2006). The addition of the extracellular matrix should therefore
be considered when engineering biosynthetic scaffolds on the
basis of alginate hydrogels, because this does not result in
(morphological and metabolic) changes of the transplanted cells
(Novikova et al. 2006). On the other hand, in particular for
clinical application, the encapsulation of cells is needed to
provideaprotectivebarrieragainsthostimmunecellinteractions
after grafting. The alginate capsules are coated with a poly-
cation, such as poly-ornithin, which forms a size exclusion
barrier that limits the size of substances that pass into and out
of the gel, so that growth factors diffuse out but immune cells
cannot target the foreign cells within the capsule (Tobias et al.
2001).Alginate-encapsulated BDNF-producing fibroblast grafts
havebeenshowntoresultinbothaxonalregrowth,whichseems
to be rather undirected and at the same time recovery offunction
after spinal cord injury. However, anterograde tract tracing did
not show any regeneration of rubrospinal axons in the recipients
of alginate-encapsulated BDNF fibroblasts (Tobias et al. 2005).
Hence, injured long descending tracts do not regrow in the
presence of alginate hydrogels containing cells secreting neuro-
trophic factors. It is, however, discussed that the amounts of
BDNF available from the alginate-encapsulated BDNF-
producing fibroblasts is substantially less than those provided
by much larger numbers of BDNF-producing fibroblasts that
were injected into the lesion gap of an injured spinal cord. The
latterapproachwasreportedto resultinregrowth of injured RST
and CST fibers ( reviewed by Deumens et al 2005). Obviously a
target for future research is the creation of alginate encapsulated
neurotrophin-producing cells, which release substantially more
of the neurotrophic factor. Nevertheless, it should be taken into
account that this approach may result on the one hand in
increased regrowth of descending fibers into the graft but on
the other hand that this ingrowth is still undirected.
The most recent development in use of alginate-
encapsulated neurotrophin-producing fibroblasts is the use
of various cross-linking methods, which allow both promo-
tion of regrowth of injured fibers and sculpting of the hydro-
gel into an optimal shape for bridging and guiding the
outgrowing nerve fibers (Francis et al. 2011).
In summary The use of alginate as a biomaterial for bridging
the injured spinal cord may result in significant CST regrowth
including the re-entry into host tissue, although this finding was
limited to one publication. Hence, more research is needed to
further analyze the effect of alginate in the repair and regener-
ation of injured CST. The use of aliginate hydrogels and aligi-
nate capsules allows the transplantation of neurotrophin-
producing cells (fibroblasts), which is a very promising ap-
proach in repair and bridging the injured spinal cord. Future
research should be aimed at the creation and transplantation of
aliginate-encapsulated cells producing substantially more of the
neurotrophic factor.
Biodegradable synthetic implants
Synthetic biodegradable implants tested for spinal cord repair
include matrigelmatrix, fibrinand fibronectin (mats)and poly
(alpha-hydroxy acids).
Matrigel
Matrigel is a soluble basal membrane extract of the
Engelbreth-Holm-Swarm tumor cell line. It forms a nonpo-
rous hydrogel at room temperature and the matrigel matrix
contains laminin, collagen IV and heparin sulphate proteo-
glycan, as well as growth factors such as insulin growth
factor-I (IGF-I). The implantation of Matrigel alone into the
injured spinal cord does not stimulate regeneration of injured
axons (Bunge 2002; Facchiano et al. 2002), an effect that is
likely to be related to the inhibitory effects of collagen IVon
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conclusive as immunohistochemical double staining revealed
that penetrating neurofilament-positive regrowing axons and
collagen IV deposits were co-localized at the lesion site in the
initial stages of axonal sprouting (between 7 and 14 days
postoperative) and were still present 1 and 2 months post-
operatively (Joosten et al. 2000). Interestingly, collagen IV-
deposits around cystic cavities, formed at the injury site
1 month post-lesion, were devoid of axons (Joosten et al.
2000). Despite the questionable role of collagen IV (as part
of the Matrigel matrix) on axon outgrowth, Matrigel has been
used as a bridge and for the local application of axon out-
growthstimulating factors and/orcells intothe lesionedspinal
cord.
Among those cells most often used for transplantation are
the Schwann cells (SC) (Bunge 2002). The use of human SC
grafts transplanted into the lesioned spinal cord immediately
after injury resulted in the regrowth of sensory and proprio-
spinalaxonsfromthegraftintothehost,althoughonlyasmall
proportion (about 1%) of the fibers entering the human SC
grafts showed evidence of regrowth from the graft into the
host spinal cord (Guest et al. 1997b). Unfortunately, these SC
graftswerecharacterized bythe absence ofingrowing severed
CSTfibers(GuestandBunge1995;Ch enetal .1996;Xuetal .
1995b). A complicating factor is the survival of the trans-
planted SC after grafting. If SC were embedded in Matrigel
and grafted within polyacrylonitrite/polyvinylchloride copol-
ymer (PAN/PVC) guidance channels, increased cell survival
was noted and at the same time the formation of a compact
cable inside the channel (Guest et al. 1997a). Strictly speak-
ing, the scaffold tested in these experiments (Guest et al.
1997a) is a composite conduit based on the combination of
non-biodegradable rigid material (PAN/PVC) filled with a
biodegradable hydrogel (matrigel).
Matrigel and local application of neurite outgrowth pro-
moting (stem) cells, in particular Schwann cell implantation,
have shown promise in overcoming many of the obstacles
facing successful repair of the injured spinal cord including
the successful survival of transplanted cell (or cell suspen-
sions). The implantation of Schwann cells as cell suspen-
sions with in situ gelling Matrigel but also with collagen as a
vehicle, after spinal cord contusion significantly enhances
long-term cell survival but not proliferation, as well as
improvement of graft vascularization and the degree of
axonal in-growth over the standard implantation vehicle
(Patel et al. 2010). The use of Matrigel to suspend cells
prior to implantation is an important consideration for
achieving improved survival and effectiveness of cellular
therapies for future clinical application. Although use of SC/
Matrigel-filled PAN-PVC guidance channels (after a com-
plete transection) did result in an improved cell survival, the
additional use of fibrin glue and acidic fibroblast growth
factor (aFGF) was needed to demonstrate regrowth of
injured anterogradely labeled CST fibers (Guest et al.
1997a). Grafting the space between the SC/Matrigel-filled
PAN/PVC bridges and the spinal cord stumps with aFGF
and fibrin glue, where the stumps of the spinal cord were
inserted 1 mm into each end of the channel, resulted in some
regrowth of injured CST fibers into the graft and at the same
time a reduced die-back of CST fibers (Guest et al. 1997a).
Obviously, in this transplantation paradigm, the use of fibrin
scaffolding is needed for regrowth of injured CST fibers [for
more on the role of fibronectin and regrowth of CST, see
“Fibrin and Fibronectin (mats)”]. At the same time, it is
worth mentioning that the type of lesion model also consid-
erably affects the outcome of the grafting procedure: if
Matrigel-embedded SCs in PAN/PVC guidance channels
were placed into partially transected spinal cords of the
adult rat, the neurons from a number of brainstem regions
extended not only their fibers into the graft but grew into the
distal spinal cord and formed bouton-like structures (Xu et
al. 1999). The response of the brainstem neurons after a
partial transection of the cord may result, at least in part,
from the restoration of cerebrospinal fluid circulation and
relatively more stable cord-graft interfaces due to the more
limited laminectomy (Bunge 2001). Additional infusion of
neurotrophins BDNF and/or NT-3 into the distal cord paren-
chyma further promoted axonal regrowth into the distal host
spinal cord (Xu et al. 1995a;B a m b e re ta l .2001). Although
NT-3 is specifically related to the guidance and outgrowth of
CST fibers (see “Development of the corticospinal tract”), the
identification of the regrowing fibers and thus the CST, is a
prime candidate to respond to this two-phase strategy, as the
fiber analysis was restricted to anterogradely labeled central
axons due to the fact that the tracer was only injected into the
spinal cord 3 mm rostral to the graft. Based on this procedure,
the exact origin of the regrowing central fibers is not clear but
atthesametimedoesnotexcludethepossibilitythatregrowing
CST fibers are involved (Bamber et al 2001).
Matrigel is not only used as a vehicle to introduce SCs
into the lesion area but also for local delivery of stem cells:
human bone marrow stromal cell-derived Schwann cells
(hBMSC-SC) (Kamada et al. 2011) or human umbilical cord
blood (HUCB) enriched with CD34-positive cells (Nishio et
al. 2006). Human bone marrow stromal cells (hBMSC) were
cultured from bone marrow of adult human patients and
induced into Schwann cells (hBMSC-SC) in vitro.
Nine days after injury, a mixture of Matrigel and hBMSC-
SC (hBMSC-SC group) was injected into the lesioned site.
Five weeks after transplantation, the application of Matrigel
and hBMSC-SC resulted in a reduced cystic cavitation and at
the same time promotion of the functional recovery (Kamada
et al. 2011). Histologically, the number of tyrosine
hydroxylase- or serotonin-positive fibers was significantly
larger at the lesion epicenter and caudal level in the
hBMSC-SC group than in the control group. However, no
384 Cell Tissue Res (2012) 349:375–395CST tract tracing was included and thus the effect of this
transplantation approach on CST regrowth still needs to be
determined.
As graft vascularization may be closely related to the
degree of axonal in-growth, further increase of blood vessel
formation or angiogenesis (and thus the survival of the trans-
planted cells) has been studied using Matrigel-containing
vascular endothelial growth factor (VEGF). With the use of
Matrigel as a vehicle, exogenous vascular endothelial growth
factor (VEGF165), either as recombinant protein alone or
combined with an adenovirus coding for VEGF165, was
applied into the lesion gap of the transected spinal cord
(Facchiano et al. 2002). The rationale behind this VEGF165
application was that the absence of regeneration of CST fibers
after injury is related to the deficiency of both blood flow and
growth factors. Hence, the exogenous addition of vascular
endothelial growth factor (VEGF165) to the transected spinal
cord, either asrecombinant protein alone or combined with an
adenovirus coding for VEGF165, was suggested to result in
an increased blood vessel formation (angiogenesis), which
might permit the regeneration of the CST fibers. The local
application of Matrigel-containing recombinant VEGF165 or
Ad.CMV.VEGF165 resulted in a reduced retrograde degener-
ation of CST axons as compared to rats treated with Matrigel
alone or Matrigel plus Ad.CMV.LACZ. (control adenovirus).
Furthermore, in rats treated with recombinant VEGF165
alone, or combined with Ad.CMV.VEGF165, a few anterog-
radely HRP-labeled CSTaxons, which were not detectable in
control rats, were seen distal to the spinal cord injury, indicat-
ing some CST regrowth across the injured area (Facchiano et
al. 2002). The failure of (CST) axons to re-enter the distal
spinal host tissue maybe in part related to the presence of the
so-called glial scar including the chondroitin sulfate proteo-
glycans (CSPGs), which inhibit axon growth (Fawcett and
Asher1999;SilverandMiller2004).Neutralizingtheseinhib-
itors with blocking antibodies and modulating their down-
stream intracellular signaling (Hannila and Filbin 2008)o r
enzymatic degradation of the CSPGs resulted in improved
axon regeneration (Kwok et al. 2008), including CST fibers
(Iseda et al. 2008). CSPGs are more heavily expressed at the
distal than the proximal interface after a complete spinal
transection and this in itself makes re-entry of injured fibers
into the distal cord much more complicated than the enhance-
ment of the sprouting in areas proximal to the lesion (Bunge
2001). Here also, the different interaction or invasion of
grafted cells (for instance, SC) embedded in a Matrigel matrix
and the proximal versus the distal stumps of the spinal cord
needs further investigation.
In summary The implantation of Matrigel alone into the
injured spinal cord does not stimulate regeneration of in-
jured axons. Hence, Matrigel is used as a vehicle for the
transplantation of cells/factors into the lesion gap after a
spinal cord injury. Many experiments have been designed
in which Matrigel is not only used as a vehicle to introduce
SCs and stem cells into the lesion but also for local delivery
molecules, which enhance the neurite growth like NT-3 and
the formation of blood vessels like VEGF. Then, an en-
hanced ingrowth of anterogradely labeled CST fibers into
the Matricel (+transplanted cells or molecules) is noted but
at the same time there is an absence of re-entry of the CST
fibers into the host in areas distal to the transplant. The latter
maybe in part related to the presence of CSPGs, which
inhibit axon growth.
Fibrin and fibronectin (mats)
As already discussed (see “Matrigel”), the additional use of
fibrin scaffolding is needed in order to stimulate the re-
growth of injured CST fibers after use and in combination
with various transplantation paradigms in the lesioned rat
spinal cord (Guest et al. 1997a). Furthermore, fibronectin
mats or fibrin scaffolds in themselves can be used to deliver
neurotrophins (or growth factors) in a controlled manner and
at the same time act as a physical bridge for regeneration.
Fibrin-based tissue engineering scaffolds not only enhance
neural fiber sprouting but at the same time delay the accu-
mulation of reactive astrocytes at the lesion in a subacute
model of spinal cord injury (Johnson et al. 2010). For
optimal delivery of drugs into the lesioned spinal cord, it
is required that the delivery system (DS) sequesters and
protects the protein (or growth factor) until the appropriate
time of release and, furthermore, that the release allows the
drug to be available to regenerating neurons or axons over a
longer period of time. An affinity-based delivery system
based on fibrin scaffolds has been developed to provide
sustained release of neurotrophins (Wood et al. 2010).
Affinity-based delivery systems allow the release of growth
factors to be controlled related to the degradation of the
delivery system and surrounding fibrin matrix (Sakiyama-
Elbert and Hubbell 2000). The delivery of NGF and GDNF
from fibrin matrices containing the affinity-based delivery
system has been shown to promote peripheral nerve regen-
eration in short-term in vivo studies and in particular the
GDNF DS demonstrated superior functional recovery as
compared to autograft controls (Wood et al. 2009, 2010).
Also, an affinity-based delivery system to release NT-3 in a
controlled manner from fibrin gels has been developed
(Taylor et al. 2004): NT-3 was immobilized within fibrin
gels via non-covalent interactions in order to slow the dif-
fusion release. Then, the release of NT-3 is mediated
through the cell-activated degradation of fibrin (Taylor et
al. 2004). The immediate implantation of NT-3 containing
fibrin scaffolds into the lesioned spinal cord enhanced the
initial regenerative response (9 days after the lesion) by
increasing neuronal fiber sprouting and cell migration into
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panied by functional improvements (Taylor et al. 2006). In a
follow-up study, the effect of controlled delivery of NT-3
from fibrin scaffolds acutely after spinal cord injury was
evaluated at the chronic stages. At 12 weeks after injury and
treatment, the animals treated with NT-3 fibrin scaffolds did
not show functional improvements and, despite the fact that
neuronal fibers were present inside the lesion, anterogradely
traced CST fibers (where these fibers were truncated or
diverted to the more dorsal white matter; Fig. 3; Taylor
and Sakiyama-Elbert 2006) and dorsal sensory tract axons
did not regrow into the lesion (Taylor and Sakiyama-Elbert
2006). In this context, a major disadvantage of the fibronec-
tin mats as well as fibrin glue acting as bridge implants is
their relatively rapid (1–2 weeks) degradation. Hence, an
alternative approach would be to perform this treatment in
the chronic phase after the lesion has stabilized.
In summary Despite significant improvements in design of
fibrin gels/mats and controlled delivery of neurotrophins
(like NT-3), a major disadvantage of the fibronectin mats
and fibrin gels is their relatively rapid degradation. Hence,
timing of the implantation of (the presently available) fibro-
nectin/fibrin bridges into the lesioned spinal cord is impor-
tant; timed implantation at chronic stages may result in
significant regeneration of injured CNS fibers including
the CST.
Poly (alpha-hydroxy acids)
The aliphatic polyesters derived from lactide, glycolide and
E-caprolactone are completely resorbable and biocompatible
in the central nervous system(Menei et al. 1993: Gautier et al.
1998). Poly(alpha-hydroxy acids), which include poly(lactic
acid) (PLA), poly(glycolic) and poly(lactic-co-glycolic acid)
(PLGA) are materials well investigated for tissue repair and
cell transplantation (Fournier et al. 2003). The resorption rate
and the mechanical properties of aliphatic polyesters can be
adjusted; as they depend primarily on the ratio of L-Lactic
acid, D-Lactic acid, glycolic acid; and E-caprolactone repeat-
ing units. In particular; the PLGA oligomers and their break-
down products have no adverse effects on the morphology,
survival and proliferation of cultured Schwann cells (Gautier
et al. 1998). In vivo cylinders made of PLGAwere integrated
into the spinal tissue 2 weeks after implantation, unlike cylin-
ders made of PLA. At all time points after surgery, the glial
and inflammatory reaction near the lesion site was unaffected by
the poly-(alpha-hydroxyacids) and growth-associated protein 43
(GAP-43) indicative for regenerating axons was observed in
fibers in the vicinity of the injury site and the remains of PLGA
and PLA cylinders (Gautier et al. 1998).
Three-dimensional PLGA or PLA scaffolds can easily be
used for the introduction of therapeutic cells into the spinal
lesion site. A type of PLGA nerve conduits is fabricated with
controllable aligned multiple channels and a hierarchical pore
microstructure in the wall (He et al. 2009). It then emerged
thatthese PLGA conduitsformeda favorable environment for
theadhesionofbonemarrow-derivedmesenchymalstemcells
(MSCs) and Schwann cells (SC). For instance, PLGA scaf-
fold–Schwann cell constructs improved hindlimb motor
recovery in a completely transected spinal cord model (Zhang
et al. 2007). Retrograde tract tracing analysis (Fast Blue
injections distal to the lesion and PLGA–SC scaffold)
revealed neuronal labeling of pyramidal cells in the cortex,
known to be the cells of origin of the CST (Chen et al. 2009).
The use and implantation of neural stem cells (NSC),
integrated into a PLGA scaffold placed into the injured
rat spinal cord, promoted long-term improvement of func-
tion (Teng et al. 2002). Furthermore, anterograde tract
tracing, at 70 days post-injury, demonstrated CST fibers
passing through the injury epicenter to the caudal cord.
Fig. 3 Corticospinal and ascending sensory tract tracing at 12 weeks.
Parasagittalsections,withrostralcordorientedtowardtop,ventralsurface
toward left. a Biotin dextran amine (BDA) anterograde tracing of the
corticospinal tract (cst) in a F-DS-NT-3 (1,000 ng/mL) treated cord. The
CSTextendsfromtherostralintactcordtowardthelesionsite.TheCSTis
located just dorsal to the gray matter (gm, indicated by dotted line), in the
most ventral part in the white matter (wm) of the dorsal funiculus. In all
groups, as fibers approached the lesion (l, border indicated by line), the
fibers were truncated or diverted to more dorsal white matter (arrow).
Infrequently, CST-positive fibers were seen in the spared dorsal matter
encircling the rostral lesion cavity (arrowhead). b Tracing of ascending
sensoryneuronswithcholeratoxinB(CTB)inF-DS-NT-3(1,000ng/mL)
treated cord. In all groups, CTB staining ended abruptly at the lesion
borderwiththeintactcord(lc).AdaptedfromTaylorandSakiyama-Elbert
(2006), with permission
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erating CST axons in and beyond the PLGA–NSC scaffolds
are characterized by their tortuous path, a phenomenon that is
most consistent with morphological profiles generally seen in
regenerating axons as opposed to spared fibers, which retain
their straight and non-tortuous profile (Teng et al. 2002).
Another use and development of a PLGA-based neural
construct was developed by Zhang et al. (2007): NT-3 and
trkC gene-modified neural stem cells were seeded in PLGA,
thereby creating an artificial construct that permitted NSCs
to differentiate into neurons establishing connections with
each other and exhibiting synaptic activity (Zhang et al.
2012; Xiong et al. 2009). However, with the use of this type
of construct, no anterogradely labeled fibers crossing the
injury site were noted, suggesting the limited ability of CST
axonal regeneration (Du et al. 2011).
Also, PLA matrices have shown biocompatibility with
cultured cells including glial cells (Maquet et al. 2000).
Whereas PLA matrices consist in macroporous polylactide
foams, which are highly oriented (Maquet et al. 2000), the
transplantation of these matrices into the injured spinal cord
resulted in preferential axon growth along the main pore
direction (Blacher et al. 2003). In vitro analysis of aligned
glial/biomatrix (PLA) complexes demonstrated that this
resulted in directing the neurite growth of neurons cultured
on top of these matrices but at the same time did not enhance
the neurite growth (Deumens et al. 2004). In particular,
OECs have been demonstrated to be very potent cells in
stimulating regrowth ofinjured CSTfibers, albeit onlyinvery
small spinal cord lesions (Li et al. 1997). Hence, a strategy
was developed that used aligned 2-dimensional PLA bridges
and OEC and olfactory nerve fibroblast (ONFs) cells trans-
planted into large spinal lesion gaps (Deumens et al. 2006). In
order to further optimize this strategy, two OEC/ONF injec-
tions were intraspinally placed either at 1 mm rostral or 1 mm
caudal to the lesion gap, thereby creating an OEC/ONF con-
tinuum. Anatomically, this approach resulted in an enhanced
presence of CST axons directly rostral to the lesion gap but
semi-quantitative analysis revealed no regrowth of CSTaxons
through the lesion site (Fig. 4)( D e u m e n se ta l .2006). Al-
though small functional behavioral improvements in the rat
were noted using the OEC/ONF-PLA continuum strategy, it
was concluded that this multifactorial transplantation strategy
has limited effects on repair of large spinal lesion gaps. Two
critical remarks need to be made, however, before we may
conclude that OEC/ONF–biomatrix bridges are not succesful
in repair of injured spinal cord. First, the bridge used consisted
in a 2-D PLA biomatrix where a 3-D biomatrix may better
mimick the developmental situation of the outgrowing CST
and therefore potentially result in better regrowth. Second, the
OEC/ONF cells did not survive on the PLA matrices and thus
no continuum was formed. The breakdown of the PLA may
Fig. 4 Biotinylated dextran amine (BDA)-labeled corticospinal tract
axons and response to OEC/ONF intervention. BDA-labeled cortico-
spinal axons were observed to approach the graft/lesion site but only
very few grew underneath the lesion and into the caudal host spinal
cord. No labeled corticospinal axons penetrated the graft/lesion site. a
Sagittal spinal cord section of an OEC/ONF-transplanted animal. The
dotted line represents the delineation of the spinal cord; the OEC/
ONF–biomatrix complex is visible within the lesion site. The four
boxes represent the boxes used in the quantitative analysis. b A
significantly higher BDA-labeling is present directly rostral to the
injury site (box 2) in transplanted animals versus control animals. Scale
bar 200 um. Adapted from Deumens et al. (2006), with permission
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area and, in combination with the putative high concentrations
of toxic substances released by pathological processes into the
large lesion gaps, may account for OEC/ONF cell death and
finally the absence of regrowing CST fibers. A similar obser-
vation (toxicity and cell death) was made in Schwann cells
genetically modified to secrete a bi-functional neurotrophin
and seeded on PLA macroporous guidance scaffolds in the
lesioned spinal cord (Hurtado et al. 2006). From these obser-
vations,itmakessensetousePLGA guidancescaffoldsseeded
with glial cells. PLGA oligomers and their breakdown prod-
ucts have been reported to have no effects on the mor-
phology, survival and proliferation of cultured Schwann
cells (Gautier et al. 1998). In this respect and in view of
the important role that vascularization (see also “Matri-
gel”) may play in optimalization of (CST) regrowth,
PLGA degradable matrices seeded with a co-culture of
neural progenitor and endothelial cells were developed.
Here, an increase of blood vessel density was observed and
formation of a blood–spinal cord barrier following SCI
(Rauch et al. 2009). Unfortunately, analysis of CST was not
included into this study (Rauch et al. 2009).
PLGA does not only function as scaffolds for cell poly-
mers but can be used for controlled release drug delivery:
neurotrophic factors can be encapsulated into PLGA nano-
particles injected into the injured spinal cord and used for a
controlled and sustained release (Wang et al. 2006; Astete
and Sabliov 2006; Benoit et al. 2000). For instance, the
therapeutic effect of PLGA nanoparticles encapsulating
glial-derived neurotrophic factor (GDNF), intraspinally
injected into the acutely injured spinal cord (Wang et al.
2006), was evaluated by examination of the preservation of
neurofilament (NF)-stained fibers and functional recovery
using the BBB locomotor rating scale (Basso et al. 1995). In
vitro and in vivo analysis showed a continuous release of
GDNF from the PLGA nanoparticles and that this induced
an increase in neuronal survival and improves better hindlimb
motor function in SCI rats (Wang et al. 2006). Interestingly,
the PLGA-GDNF nanoparticles had no effect on gliosis when
compared to that observed in SCI rats receiving PLGA injec-
tion (Wang et al. 2006).
In summary Biodegradation and breakdown of PLA may
result in an increase in toxic substances in the lesion fol-
lowed by cell death, including the transplanted cells. Future
design of three-dimensional PLGA guidance scaffolds seed-
ed with glial cells (particularly promising are the OEC/
ONF) with the main aim to re-create a continuum for re-
growth of injured CST fibers may result in significant in-
growth into the bridge and re-entry of injured CST fibers
into the host. The use of PLGA nanoparticles for a controlled
and sustained release of neurotrophins is a very promising
development in the field of biomatrices and bridging the
injured spinal cord and has already resulted in improved
hindlimb motor function in SCI rats. Follow-up studies
are needed to demonstrate the effect of local delivery of
the PLGA nanoparticles encapsulating neurotrophins on
CST regrowth.
Polyethylene glycol and chitosan
Polyethylene glycol (PEG) is a highly water soluble poly-
mer and has served as a therapeutic agent to reconstruct the
phospholipid bilayers of damaged cell membranes (or fuso-
genic activity). Based on this fusogenic property, the sys-
temic intravenous application of 30% PEG in rats that
underwent 35-g clip compression at cervical eight (C8)
resulted in a reduced neurofilament degradation and apopto-
tic cell death in the lesion area finally resulting in a modest
neurobehavioral recovery after SCI (Baptiste et al. 2009).
Retrograde tract tracing studies were not focused at the
cortex (and CST) but an increase in labeled reticulospinal
cells was noted (Baptiste et al. 2009). Hence, PEG protects
key axonal cytoskeletal proteins after SCI and this protection
is associated with axonal preservation (Cho and Borgens
2012). Also, the local application and intraspinal single injec-
tionof PEGimmediately after orat7 h after spinalcord injury
was found toreduce cystic volume and toincrease the volume
of remaining intact spinal cord parenchyma (Borgens et al
2002; Duerstock and Borgens 2002;N o v i k o v ae ta l .2003). In
a pilot trial, the intravenous application of PEG within 72 h
afteradmissionofneurologicallycompletecasesofparaplegia
in dogs was shown to result in significant neurological recov-
ery of the PEG-treated animals as compared to the untreated
controls over a 6- to 8-week trial period (Laverty et al. 2004).
The neurological improvements included deep and voluntary
pain perception,consciousperceptionofthehindlimbsaswell
as electrophysiological recording of the somatosensory
evoked potentials, whereas at the same time no clinically
relevant adverse effects to the polymer injection were noted
(Laverty et al. 2004).
In the context of membrane resealing, not only is PEG
important but also another striking example has been dem-
onstrated recently by using chitosan (Cho et al. 2010a, b).
Chitosan is bio-compatible, biodegradable, non-toxic and
can easily be prepared from the exoskeletons of crustaceans.
Chitosan has widely been used as a drug carrier and wound
healer and first indications are that this natural polymer after
topical application is capable of inducing the sealing of
neuronal membranes and restores the conduction of nerve
impulses through the length of the spinal cord preferentially
targeting the region of damage (Cho et al. 2010a, b). In
addition, chitosan can easily participate in the preparation of
microcapsules or micro/nano-spheres serving as a carrier,
which is particularly suitable for controlled drug release (for
review, see Cho and Borgens 2012)
388 Cell Tissue Res (2012) 349:375–395In addition to its fusogenic capability and reconstruc-
tion of injured axonal membranes in SCI, PEG is used to
increase the efficacy of intrathecal protein administration
into the injured SCI. PEG is the most widely used
polymer for covalent attachment of synthetic polymers
to proteins and has been shown to improve protein
half-life and penetration into tissues (Roberts et al.
2002). PEGylation of neurotrophic molecules like BDNF
(Soderquist et al. 2009) and fibroblast growth factor-2
(FGF-2) (Kang et al. 2010) has recently been described.
In both examples, the PEGylation resulted in an improve-
ment in biological activity of the protein, improvement of
the half-life (after intrathecal or delivery) and at the same
time an enhanced tissue penetration of the neurotropins
(Soderquist et al. 2009;K a n ge ta l .2010). Futher research is
needed to demonstrate a possible positive effect of intrathecal
delivery and PEGylation of neurotrophins and on CST
regrowth.
In view of the use of PEG in SCI and repair, two
important recent development needs to be mentioned
here. First, the functionalization of single-walled carbon
nanotubes with PEG (SWNT-PEG): the injection of
SWNT-PEG into the lesion at T9 1 week after a com-
plete transection decreased the lesion volume, did not
increase reactive gliosis and at the same time increased
the number of neurofilament and anterogradely labeled
CST fibers in the lesion (Roman et al. 2011). It should
be noted that, although SWNT-PEG resulted in a signif-
icant increase in CST fibers, the absolute numbers are
still extremely low, varying between 1 and 3 fibers in the
rostral-epicenter region (Roman et al. 2011). Second, the
development of injectable hydrogel scaffolds based on
PEG lightly cross-linked with poly (N-isopropylacryla-
mide) (PNIPAAm) for local delivery of neurotrophins
like BDNF or NT-3 into the lesion gap after SCI (Conova et
al. 2011; Comolli et al. 2009): it was observed that the release
of BDNF and NT-3 was sustained for up to 4 weeks and that
the bioactivity of these neurotrophins was still very good
(Comolli et a l. 2009). The PNIP-AAm-PEG hydrogels were
also compatible with bone marrow stromal cells, allowing
their survival and attachment for up to 31 days (Comolli et
al. 2009).
In summary B a s e do nt h em e m b r a n er e s e a l i n gc a p a c i t yo f
PEG (and chitosan), the intravenous application has been
shown to result in axonal preservation and a significant
neurological recovery after spinal cord injury. PEGyla-
tion of neurotrophins, functionalization of carbon nano-
tubes with PEG, or the development of injectable
hydrogel scaffolds based on PEG are interesting and
important improvements in design of successful bioma-
trices and bridges for repair of injured spinal cord, in-
cluding the CST.
Discussion
The use of degradable biomatrices for implantation into the
lesioned mammalian spinal cord has led to interesting and
important findings on CNS regeneration in general and also
in view of CST regrowth. As can be deduced from the
approaches chosen, the implementation of factors and or
cells important during the development of the spinal cord
and combined and/or integrated into a biodegradable matrix
often formed the fundaments of repair strategies. With respect
to the injured CST, main efforts have been taken to bridge the
lesion based on the re-creation or reconstruction of a 3-D
alignment of outgrowth promoting cells (immature astroglial
cells), as this typical structure is known to be present and
important during guidance and development of this tract.
Furthermore, bridging the lesion and stimulation of the
regrowth of injured CST fibers is often triggered by applica-
tion of the neurotrophin-3 (NT-3), a molecule also known to
be important during the development of this tract.
In general, it can be concluded that various approaches
have led to a significant ingrowth of anterogradely labeled
regrowing CST into the bridges. It is difficult to compare the
quality of the various bridges used but at the present mo-
ment not one single approach stands out. Furthermore, the
major drawback of all bridges currently used and developed
is the fact that no re-entry of CST fibers from the graft into
t h eh o s tt i s s u ei sn o t e d .I ti sh e r ew h e r em o s tr e s e a r c h
should be focused at. Despite the fact that various degrad-
able biomaterials in themselves do not enhance the forma-
tion of scar tissue or even minimize the impermissiveness of
the host tissue, the CSTaxons do not re-enter; obviously, the
CST fibers like it too much in the graft and are not triggered
(enough) to re-enter the host. Here, various aspects, based
on our developmental know-how, might be directive and
inform us about which approach should be taken in future
design of CNS bridges and CST regrowth. The presence of
neurotrop(h)ic molecules but also the 3D alignment of the
glial cells during development, is restricted in time and only
needed during the various phases of CST outgrowth. In
future designs of bridges and biomaterials, mimicking a
developmental CST environment is of the utmost impor-
tance; not only the presence of the cue needed for regrowth
but equally important is the disappearance or decrease in
concentration of the guidance molecule after some time. If
we again use the developmental CST as the most optimal
model needed for regrowth of injured CST fibers in the adult
mammalian spinal cord, we have learned that the develop-
ment of the CST tract is characterized by cellular interac-
tions, which are changing during the spinal outgrowth in
place and in time. It has been shown, for instance, that for
spinal target innervation the most common mechanism used
is collateral formation or back-branching, a phenomenon, at
least to my knowledge that has never been observed (or
Cell Tissue Res (2012) 349:375–395 389studied) in regrowing injured CST fibers. This back-
branching occurs after a waiting period of several days at
a defined spinal level and the neurotrophin NT-3 might be
important, although the precise mechanism underlying the
formation of the CST-collaterals is not yet known. Whereas
the injured CST axons should be triggered to re-enter the
host tissue, it should be stressed that the failure of (CST)
axons to re-enter the distal spinal host tissue maybe in part
related to the presence of the so-called glial scar, including
the chondroitin sulfate proteoglycans (CSPGs), which in-
hibit axon growth (Fawcett and Asher 1999; Silver and
Miller 2004). The much more intense expression of CSPGs
at the distal as compared to the proximal interface after a
complete spinal transection may account for the absence of
regrowth of CST fibers (Bunge 2001). CST axons are
known to terminate in CSPG-rich regions after spinal hemi-
section or contusion in rats (Iseda et al. 2008). Hence,
treatment with chondroitinase ABC and the enzymatic deg-
radation of the CSPGs resulted in the re-entry of a small
amount of the anterogradely labeled CST fibers into host
tissue (for 0.5 mm!!) in the hemisected spinal cord but not in
the contused spinal cord (Iseda et al. 2008). Obviously, in
spinal cord contusion, other axonal growth inhibitors persist
in the gliotic areas as compared to the hemisected cord.
Future: suggestions and considerations
Future development of smart biodegradable bridges for CST
regrowth in the injured spinal cord should focus on timed
release of factors and molecules required for CST regrowth,
with a very special emphasis at the re-entry of the cortico-
spinal fibers into the host-tissue. The complex of biodegrad-
ability of the matrix, the bio-availability of the growth-
stimulating molecule and the three dimensional structure
of the graft should result in an ON (“ingrowth of CST fibers
into the bridge”) and (maybe even more important!!) an
OFF mode (“allowing re-entry of the CST fibers out of
the bridge into the caudal host”). In this, the use of a bridge
does not stand alone: the formation of a continuum based on
outgrowth promoting capacities not only related to the
bridge but also including the rostral and caudal host tissue
(as initially designed and described for PLA-bridges and
OEC cells; Deumens et al. 2006) is almost certainly a pre-
requisite for succesful regeneration of the injured CST.
In the “Introduction”, it was stated that the corticospinal
tract is considered the ultimate challenge to demonstrate
whether a repair strategy is succesful in regeneration of the
injured mammalian spinal cord. In view of the almost un-
limited number of attempts and approaches undertaken (of
which in this review only the biodegradable bridges have
been discussed!!) to achieve this goal and the still very
limited success, one might suggest that the focus should
no longer be on this tract. However, it is of eminent
importance to understand the regeneration requirements of
each individual tract in the repair of the injured spinal cord.
As can be deduced from most approaches taken, evaluation
of the success of the bridge/material chosen starts with the
effect of the (new) bridging therapy on sprouting in general.
This often results in promising effects on the (neurofila-
ment-immunoreactive) regrowth of a variety of CNS fiber
populations. However, is this what we want? Obviously not,
because, if for instance the induction of regrowth of injured
motor fibers (corticospinal/rubrospinal) into the graft occurs
and at the same time an unintended induction of sprouting of
sensory fibers happens, this eventually results in deleterious
consequences. The indiscriminate promotion of sprouting of
fibers within the spinal cord after injury will result in the
formation of new and inappropriate connections between
primary afferent fibers, conveying both noxious and non-
noxious sensory information onto hyperexcitable dorsal
horn nociceptive neurons. A striking example in this respect
is the use of OEC transplantation, which not only resulted in
sprouting of motor fiber regrowth but also evoked a sprout-
ing response of the pain afferents in the tissue surrounding
the spinal lesion (Richter and Roskams 2008). In these
OEC-treated animals, autotomy of the hindlimbs was ob-
served, which is regarded as a behavioral sign of spontane-
ous pain (Kauppila 1998). From this point of view, the
behavioral analysis of repair strategies like those described
in this review, based on the induction of sprouting of injured
CNS (and CST) fibers in the lesioned spinal cord, should
include the use of (chronic) pain assays. Furthermore, this
example illustrates that the indiscriminate promotion of sprout-
ing after SCI is not the correct way but that selective regrowth
of identified fiber tracts is needed. Or, at least as a minimum,
thenewbridgingtherapyshouldbalancebetweenrestorationof
motorfunctionandatthesametimenotinduceprimaryafferent
fiber sprouting that can contribute to chronic pain. Recent
advances in our understanding of molecular inhibitors and
promoters of selective sprouting of tract- and class-specific
fibers have been reviewed (Deumens et al. 2008)
Also, from a (selective) point of motor restoration, the
regeneration of individual fiber systems is needed in order to
develop an optimal repair strategy and motor recovery. In
this respect, one important question needs to be addressed:
what is the relationship between an anatomically observed
response related to the function repair and recovery of
function? Or, do we need all injured (CST) fibers to
regenerate?
With respect to the CST, the question of which behavioral
deficits are due to CST lesioning in adult rats is still not fully
answered. Although the transection of the CST in the rat
leads to, for instance, a loss of contact placing, the role of
this tract in the control of distal and proximal limb move-
ments is still not fully understood. The good news is that it
has been documented that a very low percentage of
390 Cell Tissue Res (2012) 349:375–395regrowing fibers at the anatomical level may account for a
complete recovery of the placing reflex (Bregman et al.
1995). These observations have led to the conclusion that
recovery of specific functions can be mediated by small
numbers of descending (CST) fibers, which then influence
the local spinal circuitry. This gives hope for the future.
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